Sign in

CIK 0002007919 · <br>Emerging growth company

Inhibrx Biosciences, Inc.

Sign in to watch
Ticker
INBX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
990613523
Phone
(858) 795-4220
Business address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
  1. POS EX Other Post-effective Amendment
  2. 424B3 Offering Prospectus
  3. 8-K Event Results of operations
  4. 10-K Report Annual Report
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 424B3 Offering Prospectus
  9. 8-K Event Regulation FD disclosure · Other events
  10. 424B3 Offering Prospectus
  11. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
  12. 4 Gift Director gave 500,000 shares (gift)
  13. 4 Gift Director gave 52,000 shares (gift)
  14. 4 Open-market buy Director bought 107,186 shares at an average $14.21 ($1,523,620)
  15. SC 13G Stake Amended Statement of Ownership
  16. 424B3 Offering Prospectus
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. 424B3 Offering Prospectus
  20. 8-K Event Other events

Page 5 of 8 · 158 filings